Literature DB >> 34875651

Can Understanding Outcomes for Medicare Advantage Enrollees Reduce Racial and Ethnic Disparities in Kidney Disease?

Keith C Norris1.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34875651      PMCID： PMC8758522          DOI： 10.1159/000519759

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN： 0250-8095            Impact factor:   3.754


× No keyword cloud information.
  9 in total

1.  Invited commentary: "race," racism, and the practice of epidemiology.

Authors:  C P Jones
Journal:  Am J Epidemiol       Date:  2001-08-15       Impact factor: 4.897

2.  Concentration of Physician Services Across Insurers and Effects on Quality: Early Evidence From Medicare Advantage.

Authors:  W Pete Welch; Aditi P Sen; Andrew B Bindman
Journal:  Med Care       Date:  2019-10       Impact factor: 2.983

3.  A predictive model for progression of chronic kidney disease to kidney failure.

Authors:  Navdeep Tangri; Lesley A Stevens; John Griffith; Hocine Tighiouart; Ognjenka Djurdjev; David Naimark; Adeera Levin; Andrew S Levey
Journal:  JAMA       Date:  2011-04-11       Impact factor: 56.272

4.  Racial Disparities in Nephrology Consultation and Disease Progression among Veterans with CKD: An Observational Cohort Study.

Authors:  Jonathan Suarez; Jordana B Cohen; Vishnu Potluri; Wei Yang; David E Kaplan; Marina Serper; Siddharth P Shah; Peter Philip Reese
Journal:  J Am Soc Nephrol       Date:  2018-08-17       Impact factor: 10.121

5.  Patient Experiences of Integrated Care in Medicare Accountable Care Organizations and Medicare Advantage Versus Traditional Fee-for-Service.

Authors:  Molly Frean; Christian Covington; Maike Tietschert; Hassina Bahadurzada; Jodi So; Sara J Singer
Journal:  Med Care       Date:  2021-03-01       Impact factor: 2.983

6.  The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Michael G Shlipak; Sri Lekha Tummalapalli; L Ebony Boulware; Morgan E Grams; Joachim H Ix; Vivekanand Jha; Andre-Pascal Kengne; Magdalena Madero; Borislava Mihaylova; Navdeep Tangri; Michael Cheung; Michel Jadoul; Wolfgang C Winkelmayer; Sophia Zoungas
Journal:  Kidney Int       Date:  2020-10-27       Impact factor: 10.612

7.  Disparities in Chronic Kidney Disease Progression by Medicare Advantage Enrollees.

Authors:  Clarissa Jonas Diamantidis; Lindsay Zepel; Virginia Wang; Valerie A Smith; Sarah Hudson Scholle; Loida Tamayo; Matthew L Maciejewski
Journal:  Am J Nephrol       Date:  2021-12-07       Impact factor: 3.754

8.  Back to the Future: Glomerular Hyperfiltration and the Diabetic Kidney.

Authors:  Katherine R Tuttle
Journal:  Diabetes       Date:  2017-01       Impact factor: 9.461

9.  High sodium intake, glomerular hyperfiltration, and protein catabolism in patients with essential hypertension.

Authors:  Giacomo Rossitto; Giuseppe Maiolino; Silvia Lerco; Giulio Ceolotto; Gavin Blackburn; Sheon Mary; Giorgia Antonelli; Chiara Berton; Valeria Bisogni; Maurizio Cesari; Teresa Maria Seccia; Livia Lenzini; Alessio Pinato; Augusto Montezano; Rhian M Touyz; Mark C Petrie; Ronan Daly; Paul Welsh; Mario Plebani; Gian Paolo Rossi; Christian Delles
Journal:  Cardiovasc Res       Date:  2021-04-23       Impact factor: 10.787
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.